# TG Therapeutics

> a commercial stage biopharmaceutical company

**Wikidata**: [Q106301317](https://www.wikidata.org/wiki/Q106301317)  
**Source**: https://4ort.xyz/entity/tg-therapeutics

## Summary
TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company based in the United States. It is a publicly traded corporation listed on the Nasdaq stock exchange, operating under the ticker symbol TGTX. 

## Key Facts
- **Company Name:** TG Therapeutics, Inc.
- **Description:** A commercial-stage biopharmaceutical company.
- **Corporate Classification:** Public company.
- **Stock Exchange:** Listed on the Nasdaq stock exchange.
- **Ticker Symbol:** TGTX
- **Headquarters:** New York City
- **Country:** United States
- **ISIN:** US88322Q1085
- **LEI (Legal Entity Identifier):** 529900X21UKABN9NJ529
- **CIK (Central Index Key):** 0001001316
- **Website:** http://tgtherapeutics.com
- **Twitter Handle:** @TGTherapeutics
- **LinkedIn ID:** tg-therapeutics
- **Crunchbase Organization ID:** tg-therapeutics
- **Golden ID:** TG_Therapeutics-K46DM98
- **Freebase ID:** /m/0x2zfq5

## FAQs
**What type of company is TG Therapeutics?**
TG Therapeutics is a commercial-stage biopharmaceutical company that operates as a publicly traded corporation. It is registered in the United States and maintains its headquarters in New York City.

**Where is TG Therapeutics' stock traded?**
The company's securities are traded publicly on the Nasdaq stock exchange under the ticker symbol TGTX. Its International Securities Identification Number (ISIN) is US88322Q1085.

**How can I find TG Therapeutics online or on professional networks?**
You can visit their official website at http://tgtherapeutics.com, follow them on Twitter under the handle @TGTherapeutics, or find their corporate profile on LinkedIn under the ID tg-therapeutics.

## Why It Matters
As a public commercial-stage biopharmaceutical company, TG Therapeutics represents a corporate entity that bridges healthcare innovation with public capital markets. By being publicly traded on the Nasdaq, it provides an opportunity for general public shareholders to invest in the biopharmaceutical sector. The company's classification as a "commercial stage" entity indicates its role in the active marketing and sale of biopharmaceutical products, a phase that impacts patient care and the broader medical landscape.

## Notable For
*   Operating as a commercial-stage biopharmaceutical company, which signifies a transition past the purely clinical or research phases into commercial market activities.
*   Being a publicly traded company on the Nasdaq exchange, adhering to the regulatory, reporting, and disclosure standards required of publicly held corporations.
*   Maintaining its corporate headquarters in New York City, situating its operations within a major global financial and commercial hub.

## Body

### Corporate Identity and Classification
TG Therapeutics, legally known as TG Therapeutics, Inc., operates as a commercial-stage biopharmaceutical company. Structurally, it is classified as a public company, meaning it offers its securities—such as stock—for sale to the general public. This corporate form is a specific legal type of joint-stock company and enterprise where ownership is distributed among general public shareholders. As a publicly traded entity, it is distinctly different from a private company or a state-owned public enterprise.

### Financial Market Presence
The company is listed on the Nasdaq stock exchange under the ticker symbol TGTX. It is identified in financial and regulatory systems by several key identifiers: an International Securities Identification Number (ISIN) of US88322Q1085, a Central Index Key (CIK) of 0001001316, and a Legal Entity Identifier (LEI) of 529900X21UKABN9NJ529. These identifiers facilitate its regulation, transparency, and trading within U.S. public markets.

### Location and Operations
TG Therapeutics is headquartered in New York City, United States. Its operational base in a major U.S. economic center aligns with its status as a domestic public enterprise.

### Digital Footprint and References
The company maintains a public-facing digital presence through its official website and various professional databases. Its corporate website is located at http://tgtherapeutics.com. On social media and professional platforms, it is represented on Twitter as @TGTherapeutics and on LinkedIn with the ID tg-therapeutics. The organization is also indexed in major corporate knowledge bases, holding the Crunchbase organization ID of tg-therapeutics, the Golden ID TG_Therapeutics-K46DM98, and the Freebase ID /m/0x2zfq5.

## References

1. [Crunchbase](http://www.crunchbase.com/organization/tg-therapeutics)
2. Global LEI Index
3. [Source](https://golden.com/wiki/TG_Therapeutics-K46DM98)